|   | ![]() Your Search for ACTIS or AIDS Clinical Trials Information Service matched 213 Documents (Page 1 of 8). Results Indexed by relevance. |
| 1. |
Use of federal HIV/AIDS treatment information resources by HIV-infected and -affected women. (72%) Abstract: Introduction: Analysis of gender and requester types recorded by the staff of the HIV/AIDS Treatment Information Service (ATIS) and the AIDS Clinical Trials Information Service (ACTIS) indicate that women utilize these federal information resources more as caregivers than as patients. Although the proportion of HIV+ f ... http://www.aegis.org/aidsline/1997/dec/m97c1200.html File Name: m97c1200.html, Size: 9KB, Last Modified: Sunday, December 28, 1997 at 8:12:04 PM |
| 2. |
Special Bulletin: Trials Open to Enrollment. (70%) Abstract: All NIH sponsored clinical trials are once again open to enrollment. Call the AIDS Clinical Trials Information Service at 1-800-TRIALS-A for additional information. ... http://www.aegis.org/news/ads/1996/ad960074.html File Name: ad960074.html, Size: 8KB, Last Modified: Friday, January 12, 1996 at 3:00:00 PM |
| 3. |
HIV/AIDS Clinical Trials Videotape Package Now Available (57%) Abstract: The new HIV/AIDS Clinical Trials: Knowing Your Options videotape package is now available from the AIDS Clinical Trials Information Service (ACTIS). ACTIS is a national information and referral service that provides the latest details on federally and privately sponsored clinical trials for experimental drugs and othe ... http://www.aegis.org/news/ads/1996/ad961159.html File Name: ad961159.html, Size: 9KB, Last Modified: Wednesday, June 19, 1996 at 3:00:00 PM |
| 4. |
The national AIDS information clearinghouse. (57%) Abstract: OBJECTIVE: To provide comprehensive information about HIV/AIDS service organizations, clinical trials and educational materials to public health managers, health professionals and AIDS service providers. METHODS: The National AIDS Information Clearinghouse (NAIC) was initiated in October 1987 by the Public Health Serv ... http://www.aegis.org/aidsline/1990/dec/m90c0638.html File Name: m90c0638.html, Size: 9KB, Last Modified: Friday, December 28, 1990 at 8:12:04 PM |
| 5. |
AEGiS-06IAC: The national AIDS information clearinghouse. (57%) Abstract: <p><b>OBJECTIVE</b>: To provide comprehensive information about HIV/AIDS service organizations, clinical trials and educational materials to public health managers, health professionals and AIDS service providers.</p> <p><b>METHODS</b>: The National AIDS Information Clearinghouse (NAIC) was initiated in October 1987 ... http://www.aegis.org/conferences/iac/1990/4081.html File Name: 4081.html, Size: 6KB, Last Modified: Wednesday, June 20, 1990 at 8:12:04 PM |
| 6. |
AEGiS-FDA: ACTIS and ATIS merge into single website - http://www.AIDSinfo.nih.gov (43%) Abstract: On December 2, 2002, the HIV/AIDS Clinical Trials Information Service (ACTIS) and its sister service, the HIV/AIDS Treatment Information Service (ATIS), will be merged into a single website called http://www.AIDSinfo.nih.gov. The AIDSinfo project will include all of the services already available from ACTIS and ATIS, a ... http://www.aegis.org/news/fda/2002/fd021201.html File Name: fd021201.html, Size: 8KB, Last Modified: Tuesday, March 06, 2007 at 5:40:18 PM |
| 7. |
AEGiS-IRIN: World Vaccine Day Celebrated (43%) Abstract: The 4th Annual HIV Vaccine Awareness Day on Friday recognised the thousands of women and men worldwide who have participated in research studies to test experimental HIV vaccines, an ACTIS statement said. Since the first studies in humans in 1987, more than 12,000 individuals have stepped forward to volunteer in vaccin ... http://www.aegis.org/news/irin/2001/ir010518.html File Name: ir010518.html, Size: 8KB, Last Modified: Saturday, May 19, 2001 at 3:00:00 PM |
| 8. |
AEGiS-BETA: Currently Enrolling HIV/AIDS Vaccine Clinical Trials - Year-End, 1999 (43%) Abstract: Trial protocols are available at the AIDS Clinical Trials Information Service (ACTIS). Call 800-TRIALS-A, or visit the ACTIS Web site at www.actis.org. ... http://www.aegis.org/pubs/beta/1999/be991224.html File Name: be991224.html, Size: 7KB, Last Modified: Wednesday, April 04, 2001 at 12:58:45 AM |
| 9. |
HIV+ Issue 8 - Finding your way in the trials network (43%) Abstract: April 2000 May. NUMBER EIGHT. HIV AND WOMEN: A SPECIAL REPORT. TRIAL, NOT ERROR Finding your way in the trials network. The AIDS Clinical Trials Group, or ACTG is the largest clinical trials network in the world. It is slated to spend $80 million dollars in the year 2000 alone. In the United States, two other groups sp ... http://www.aegis.org/pubs/hivplus/issue8/report/trial.html File Name: trial.html, Size: 8KB, Last Modified: Saturday, October 07, 2000 at 8:16:45 PM |
| 10. |
New Internet Sources for HIV/AIDS Treatment and Clinical Trials Information (43%) Abstract: Information on treatment for HIV infection and HIV/AIDS clinical trials will now be available through two new World Wide Web sites. The HIV/AIDS Treatment Information Service (ATIS) Web site, http://www.hivatis.org, provides information on federally approved treatments for HIV infection, treatment- related publication ... http://www.aegis.org/news/ads/1996/ad960500.html File Name: ad960500.html, Size: 9KB, Last Modified: Friday, March 15, 1996 at 3:00:00 PM |
| 11. |
"AIDS Clinical Trials Information" (43%) Abstract: The AIDS Clinical Trials Information Service (ACTIS) provides information on federally and privately sponored clinical trials of possible drugs and therapies to treat HIV and AIDS-defining illnesses. ACTIS, a resource for HIV-infected persons and their families, is funded by the Centers for Disease Control, the Food ... http://www.aegis.org/news/ads/1991/ad911783.html File Name: ad911783.html, Size: 9KB, Last Modified: Wednesday, October 02, 1991 at 3:00:00 PM |
| 12. |
AEGiS-ATN: New Government AIDS Web Site, Phone Number (35%) Abstract: A new government Web site -- http://www.aidsinfo.nih.gov -- merges two previous services (AIDS Clinical Trials Information Service, and AIDS Treatment Information Service), plus other government-approved AIDS information. For those who prefer to call, the telephone help line hours are noon to 5 p.m. Monday through Frid ... http://www.aegis.org/pubs/atn/2002/atn38606.html File Name: atn38606.html, Size: 8KB, Last Modified: Monday, January 12, 2009 at 9:59:53 PM |
| 13. |
(ATN) Pediatric Trial of 141W94, Vertex Protease Inhibitor (35%) Abstract: A new trial of the protease inhibitor 141W94 (formerly called VX-478) is seeking 210 children and adolescents between 6 months ... http://www.aegis.org/pubs/atn/1997/atn27502.html File Name: atn27502.html, Size: 6KB, Last Modified: Monday, January 12, 2009 at 9:58:36 PM |
| 14. |
(ATN) DOXIL Available in Government Trial (35%) Abstract: An important government study is now recruiting 120 volunteers with advanced KS to compare DOXIL alone vs. DOXIL plus BV (bleomycin and vincristine). Everyone in this trial will get DOXIL; half of the participants will get the other drugs too. Both treatment will be given every two weeks, for a maximum of 25 treatments ... http://www.aegis.org/pubs/atn/1995/atn23604.html File Name: atn23604.html, Size: 7KB, Last Modified: Monday, January 12, 2009 at 9:58:07 PM |
| 15. |
(ATN) Boston, Galveston, Jackson County, Jefferson County, New York City, Portland -- New Saquinavir Trial (35%) Abstract: Hoffmann-La Roche is recruiting for a 90-patient trial to compare different doses of a new formulation of saquinavir , its protease inhibitor, with the conventional formulation now being used in major clinical trials and in the expanded- access lottery. The new formulation is the same drug, but deliver ... http://www.aegis.org/pubs/atn/1995/atn23107.html File Name: atn23107.html, Size: 8KB, Last Modified: Monday, January 12, 2009 at 9:58:03 PM |
| 16. |
(ATN) New York: Hypericin Trial Recruiting, P24 No Longer Needed (35%) Abstract: The ongoing trial of the antiviral hypericin at New York University has been changed to compare oral vs. intravenous doses of the drug; previously it only tested intravenous administration. Volunteers no longer need to be p24 positive -- an inclusion criterion which had been a problem in New York, since the p24 antigen ... http://www.aegis.org/pubs/atn/1993/atn16704.html File Name: atn16704.html, Size: 8KB, Last Modified: Monday, January 12, 2009 at 9:57:22 PM |
| 17. |
(ATN) Oral Ganciclovir CMV Prophylaxis Study Recruiting (35%) Abstract: A major national study is testing an oral form of the anti- CMV drug ganciclovir to see if it can prevent CMV disease in patients who do not have it already. This trial is for persons with AIDS and with T-helper counts under 100 -- or persons without AIDS and T-helper counts under 50. There are various other entry cri ... http://www.aegis.org/pubs/atn/1993/atn16703.html File Name: atn16703.html, Size: 8KB, Last Modified: Monday, January 12, 2009 at 9:57:22 PM |
| 18. |
Selected open clinical trials for HIV/AIDS treatments. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 2714. (35%) Abstract: Information about newly-opened clinical trials that involve treatments for HIV infection; cryptosporidiosis-associated diarrhea; malignancies and cancers; wasting and myopathy; immune enhancement; and treatment options for children, adolescents, and women are presented. Additional information is available by calling t ... http://www.aegis.org/aidsline/1996/jun/m9660215.html File Name: m9660215.html, Size: 8KB, Last Modified: Thursday, January 08, 2009 at 1:03:31 AM |
| 19. |
AIDS clinical trials information service [news] (35%) Abstract: ... http://www.aegis.org/aidsline/1989/oct/m89a0468.html File Name: m89a0468.html, Size: 7KB, Last Modified: Wednesday, January 07, 2009 at 5:30:03 AM |
| 20. |
AEGiS-FDA: AIDS Treatment Registry (35%) Abstract: HHS Secretary Louis W. Sullivan, M.D., today announced the completion of computerized listings through which AIDS patients and their doctors can get up-to-date information on clinical trials of AIDS drugs and vaccines -- whether federally or privately sponsored -- and the general criteria for participating in them. T ... http://www.aegis.org/news/fda/1989/fd890701.html File Name: fd890701.html, Size: 8KB, Last Modified: Tuesday, March 06, 2007 at 5:40:11 PM |
| 21. |
Open clinical trials for HIV/AIDS treatments. (35%) Abstract: Open clinical trials for HIV/AIDS treatments are described. All listings are taken from the Trials Search database, the American Foundation for AIDS Research web site, and the AIDS Clinical Trials Information Service site. Internet addresses and telephone numbers are included. The criteria and study design for each tr ... http://www.aegis.org/aidsline/2000/nov/a00b0364.html File Name: a00b0364.html, Size: 8KB, Last Modified: Tuesday, November 28, 2000 at 8:12:04 PM |
| 22. |
(NIAID) HIV-Related Candidiasis (35%) Abstract: NIAID) HIV-Related Candidiasis. Prepared by: Office of Communications National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, MD 20892 Public Health Service U.S. Department of Health and Human Services April 1995Candidiasis is a yeast infection caused by Candida ... http://www.aegis.org/news/niaid/1995/na950402.html File Name: na950402.html, Size: 6KB, Last Modified: Monday, September 21, 1998 at 1:34:19 PM |
| 23. |
(CDC) Viatical Settlements (35%) Abstract: This is a statement from the Federal Trade Commission (FTC) concerning ... http://www.aegis.org/pubs/cdchotb/1996/hb168.html File Name: hb168.html, Size: 7KB, Last Modified: Saturday, August 15, 1998 at 4:58:41 PM |
| 24. |
NIAID FACT SHEET: Toxoplasmosis (35%) Abstract: NIAID FACT SHEET: Toxoplasmosis. National Institute of Allergy and Infectious Diseases, National Institutes of Health - April 1994 Toxoplasmosis is an infection that is caused by the parasite Toxoplasma gondii. The parasite is carried by cats, birds, and other animals and is found in soil contaminated by ca ... http://www.aegis.org/news/niaid/1994/na940023.html File Name: na940023.html, Size: 6KB, Last Modified: Friday, August 07, 1998 at 4:09:23 PM |
| 25. |
NIAID Begins First Test of Novel HIV Peptide Vaccine (35%) Abstract: NIAID Begins First Test of Novel HIV Peptide Vaccine. News from NIAID - February 12, 1993 National Institute of Allergy and Infectious Diseases, National Institutes of HealthThe. National Institute of Allergy. and Infectious Diseases (. has begun the first human trials of an experimental vaccine containing seve ... http://www.aegis.org/news/niaid/1993/cdc93023.html File Name: cdc93023.html, Size: 6KB, Last Modified: Tuesday, July 21, 1998 at 3:03:49 PM |
| 26. |
Open clinical trials for HIV/AIDS treatments. (35%) Abstract: Information on new or changed clinical trials is presented, and users are directed to the AIDS Clinical Trials Information Service for further information on specific trials. The trials detailed include antiretroviral treatments, treatments for opportunistic infections, treatments for malignancies and cancers, and tri ... http://www.aegis.org/aidsline/1998/mar/m9830075.html File Name: m9830075.html, Size: 8KB, Last Modified: Sunday, March 29, 1998 at 6:29:23 AM |
| 27. |
Open clinical trials for HIV/AIDS treatments. (35%) Abstract: Information on new or changed clinical trials is presented, and users are directed to the AIDS Clinical Trials Information Service for further information on specific trials. The trials that are reviewed are studying antiretroviral treatments, treatments for opportunistic infections, treatments for malignancies and ca ... http://www.aegis.org/aidsline/1997/dec/m97c1092.html File Name: m97c1092.html, Size: 8KB, Last Modified: Sunday, December 28, 1997 at 8:12:04 PM |
| 28. |
Pediatric trial of 141W94, Vertex protease inhibitor. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. (35%) Abstract: A new trial of the experimental protease inhibitor 141W94 VX-478) is being conducted with protease inhibitor-naive patients aged between 6 months and 18 years, and with viral loads of at least 10,000 copies. The trial is testing antiviral effect at 16 weeks and durability at 48 weeks. A phase III study of adult patien ... http://www.aegis.org/aidsline/1997/dec/m97c1569.html File Name: m97c1569.html, Size: 8KB, Last Modified: Sunday, December 28, 1997 at 8:12:04 PM |
| 29. |
CMV retinitis, newly diagnosed: RS-79070 trial in Atlanta, Austin, Boston, Durham, Houston, Irvine, Los Angeles (?), Miami, Montreal, New York (3 sites), San Diego, San Francisco (3 sites), Toronto, and Washington. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. (35%) Abstract: A multicenter study using RS-79070 for newly-diagnosed cytomegalovirus retinitis is enrolling patients. Current sites include Atlanta, Austin, Boston, Durham, Houston, Irvine, Los Angeles, Miami, Montreal, New York, San Diego, San Francisco, Toronto, and Washington. For further inf ... http://www.aegis.org/aidsline/1997/sep/m9790152.html File Name: m9790152.html, Size: 8KB, Last Modified: Sunday, September 28, 1997 at 8:12:04 PM |
| 30. |
GS 840 (adefovir dipivoxil): broad-spectrum antiviral trial, CD4 count under 100. (35%) Abstract: A study is seeking more than 2,000 volunteers for a phase III trial of GS 840 (also called adefovir dipivoxil, or bis-POM PMEA), to test whether the drug, taken orally once a day, can increase survival of persons with advanced HIV, and also whether it can prevent the development of ... http://www.aegis.org/aidsline/1997/jun/m9760045.html File Name: m9760045.html, Size: 8KB, Last Modified: Saturday, June 28, 1997 at 8:12:04 PM |
|   |
|
|   |
|